Professor Tim Maughan, Clinical Director of the Cancer Research UK / Medical Research Council Oxford Institute for Radiation
Oncology, said «This
novel and exciting finding provides a new scientific basis for
precision targeting of some cancers which are currently very difficult to treat, and we are now taking these findings into clinical trials.»